D-1011-2019 Class II Terminated

Recalled by Akorn Inc — Lake Forest, IL

FDA drug recall D-1011-2019 was initiated by Akorn Inc on Mar 12, 2019 and is designated Class II. Reason for recall: Sub Potent Drug: OOS results observed for the Hydrocortisone assay during routine stability testing at 12 month controlled room temperature. The recall status is terminated (terminated Aug 1, 2022). Affected quantity: 15,322 10 ml bottles.

Recall details

Product Type
Drugs
Report Date
Mar 27, 2019
Initiation Date
Mar 12, 2019
Termination Date
Aug 1, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
15,322 10 ml bottles

Product description

Hydrocortisone and Acetic Acid Otic Solution, USP, 10 mL per dropper bottle, Rx only, Hi-Tech Pharmacal Co, Inc., Amityville, NY 11701. NDC: 50383-901-10

Reason for recall

Sub Potent Drug: OOS results observed for the Hydrocortisone assay during routine stability testing at 12 month controlled room temperature.

Distribution pattern

Nationwide USA and Puerto Rico

Code information

Lot: 357647, EXP 04/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1011-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1011-2019. Report a data issue: hello@regdatalab.com.